SCHEMBL4144014

SCHEMBL4144014

COc1ccc(C(=O)N2Cc3ccccc3C2)c(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 13/20 0.71
HSP90AB1 P08238 9/20 0.71
TRAP1 Q12931 4/20 0.63
HSP90B1 P14625 3/20 0.63
HPGD P15428 3/20 0.56
LMNA P02545 2/20 0.56
CYP1A2 P05177 2/20 0.56
PGR P06401 2/20 0.56
SLC6A2 P23975 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP3A4 P08684 2/20 0.56
ADORA3 P0DMS8 1/20 0.56
AR P10275 1/20 0.56
CHRM1 P11229 1/20 0.56
ALOX15 P16050 1/20 0.56
TBXA2R P21731 1/20 0.56
ADRA1A P35348 1/20 0.56
HIF1A Q16665 1/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151333 0.89 TRAP1 (0.65) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL4159578 0.87 HSP90AA1 (0.61) HSP90AA1HSP90AB1TRAP1HSP90B1NPC1
SCHEMBL31335790 0.83 HSP90AA1 (1.00) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL383175 0.83 HSP90AA1 (1.00) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL4145940 0.81 HSP90AA1 (0.72) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL383886 0.78 HSP90AA1 (0.71) HSP90AA1HSP90AB1HSP90B1
SCHEMBL4156177 0.78 HSP90AA1 (0.72) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL4150717 0.78 HSP90AA1 (0.72) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL382221 0.78 HSP90AB1 (0.74) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL3813722 0.77 HSP90AA1 (0.51) HSP90AA1HSP90AB1TRAP1HSP90B1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885TRAP1 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.